, Free trade Agreement between the European Union and the Republic of Singapore

In forcesince 17 Apr 2020
1.

Singapore shall not require product filing or approval for insurance products other than for life insurance products [Life insurance products here would include non-short term accident and health policies and term policies exceeding five years.], Central Provident Fund-related products and investment-linked products. Where product filing or approval is required, Singapore shall allow the introduction of the product, which Singapore shall deem to be approved unless the product is disapproved within a reasonable time, endeavouring to do so in 30 days. Singapore shall not maintain limitations on the number or frequency of product introduction. This specific commitment does not apply where a financial institution of the Union seeks to supply a new financial service pursuant to Article 8.53 (New Financial Services).